Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR

We reported a relevant activity of the combination between sorafenib and octreotide long-acting release (LAR) in advanced hepatocellular carcinoma (HCC) patients. In this work, we have studied if oxidative stress in both serum and peripheral blood mononuclear cells (PBMC) and pERK activation status...

Descripción completa

Detalles Bibliográficos
Autores principales: Caraglia, M, Giuberti, G, Marra, M, Addeo, R, Montella, L, Murolo, M, Sperlongano, P, Vincenzi, B, Naviglio, S, Prete, S Del, Abbruzzese, A, Stiuso, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122065/
https://www.ncbi.nlm.nih.gov/pubmed/21525937
http://dx.doi.org/10.1038/cddis.2011.34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122065/
https://www.ncbi.nlm.nih.gov/pubmed/21525937
http://dx.doi.org/10.1038/cddis.2011.34

Ejemplares similares